Positions

Selected Publications

Academic Article

Year Title Altmetric
2018 Wnt receptor Frizzled 8 is a target of ERG in prostate cancer.Prostate.  78:1311-1320. 2018
2018 Detection of BRAF V600E Mutations With Next-Generation Sequencing in Infarcted Thyroid Carcinomas After Fine-Needle Aspiration.American Journal of Clinical Pathology.  150:177-185. 2018
2018 Single molecule mtDNA fiber FISH for analyzing numtogenesis.Analytical Biochemistry.  552:45-49. 2018
2018 miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.Cell Growth and Differentiation.  16:1125-1137. 2018
2018 Hsp70 and gama-Semino protein as possible prognostic marker of prostate cancer.Frontiers in Bioscience.  23:1987-2000. 2018
2017 Bromoethylindole (BEI-9) redirects NF-κB signaling induced by camptothecin and TNFα to promote cell death in colon cancer cells.Apoptosis.  22:1553-1563. 2017
2017 Prostate cancer health disparities: An immuno-biological perspective.Cancer Letters.  414:153-165. 2017
2017 Molecular characterization of pro-metastatic functions of β4-integrin in colorectal cancer.Oncotarget.  8:92333-92345. 2017
2017 Prolonged exposure of resveratrol induces reactive superoxide species-independent apoptosis in murine prostate cells.Tumor Biology.  39:1010428317715039. 2017
2017 Functional consequence of the p53 codon 72 polymorphism in colorectal cancer.Oncotarget.  8:76574-76586. 2017
2017 Label-free detection of DNA hybridization with a compact LSPR-based fiber-optic sensor.Analyst.  142:1974-1981. 2017
2017 Resveratrol induces mitochondria-mediated, caspase-independent apoptosis in murine prostate cancer cells.Oncotarget.  8:20895-20908. 2017
2017 Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer.Oncotarget.  8:20198-20212. 2017
2016 Molecular Biomarkers of Colorectal Cancer and Cancer Disparities: Current Status and Perspective.Current Colorectal Cancer Reports.  12:332-344. 2016
2016 Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancer.Cancer Letters.  374:304-314. 2016
2016 Targeting Hsp70: A possible therapy for cancer.Cancer Letters.  374:156-166. 2016
2016 A comparison of 12-gene colon cancer assay gene expression in African American and Caucasian patients with stage II colon cancer.BMC Cancer.  16:368. 2016
2016 Association between Hepatitis C Virus Infection, p53 Phenotypes, and Gene Variants of Adenomatous Polyposis Coli in Hepatocellular Carcinomas.J Dig Dis Hepatol.  2016. 2016
2015 Antitumor activity of melinjo (Gnetum gnemon L.) seed extract in human and murine tumor models in vitro and in a colon-26 tumor-bearing mouse model in vivo.Cancer Medicine.  4:1767-1780. 2015
2015 Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.Oncotarget.  6:27763-27777. 2015
2015 3-(2-Bromoethyl)-indole inhibits the growth of cancer cells and NF-κB activation.Oncology Reports.  34:495-503. 2015
2015 Nanomagnetic levitation three-dimensional cultures of breast and colorectal cancers.Journal of Surgical Research.  194:319-326. 2015
2015 IND-2, a pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinoline derivative, circumvents multi-drug resistance and causes apoptosis in colon cancer cells.Bioorganic and Medicinal Chemistry.  23:602-611. 2015
2015 Clinical Implications of Rabphillin-3A-Like Gene Alterations in Breast Cancer.PLoS ONE.  10:e0129216. 2015
2014 Variable NF-κB pathway responses in colon cancer cells treated with chemotherapeutic drugs.BMC Cancer.  14:599. 2014
2014 A New Robust Method for Nonlinear Regression.Journal of Biometrics and Biostatistics.  5:211. 2014
2014 Disparities in cervical cancer mortality rates as determined by the longitudinal hyperbolastic mixed-effects type II model.PLoS ONE.  9:e107242. 2014
2014 Robust Logistic and Probit Methods for Binary and Multinomial Regression.Journal of Biometrics and Biostatistics.  5. 2014
2013 The Chemokine CXCL8 in Carcinogenesis and Drug Response.ISRN Oncology.  2013:859154. 2013
2013 Clinical implications of microRNAs in cancer.Stain technology.  88:388-396. 2013
2013 Post-transcriptional processing of genetic information and its relation to cancer.Stain technology.  88:365-372. 2013
2013 The prognostic value of microRNAs varies with patient race/ethnicity and stage of colorectal cancer.Clinical Cancer Research.  19:3955-3965. 2013
2013 Nef-M1, a CXCR4 Peptide Antagonist, Enhances Apoptosis and Inhibits Primary Tumor Growth and Metastasis in Breast Cancer.Journal of Cancer Therapy.  4:898-906. 2013
2013 Socioeconomic status, p53 abnormalities, and colorectal cancer.Journal of Gastrointestinal Oncology.  4:40-44. 2013
2013 Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53.Stain technology.  88:38-46. 2013
2012 Pseudoangiomatous stromal hyperplasia (PASH) of the breast: a series of 24 patients.Breast Journal.  18:242-247. 2012
2012 Characterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: the role of rs67491583.Cancer Genetics.  205:25-33. 2012
2012 Dual-mode interaction between quercetin and DNA-damaging drugs in cancer cells.Anticancer Research.  32:61-71. 2012
2012 Prognostic significance and gene expression profiles of p53 mutations in microsatellite-stable stage III colorectal adenocarcinomas.PLoS ONE.  7:e30020. 2012
2012 miRNAs are stable in colorectal cancer archival tissue blocks.Frontiers in bioscience (Elite edition).  4:1937-1940. 2012
2011 Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue.Journal of Clinical Oncology.  29:4620-4626. 2011
2011 Evaluation of lymph node numbers for adequate staging of Stage II and III colon cancer.Journal of Hematology & Oncology.  4:25. 2011
2011 Erratum: Development of combination tapered fiber-optic biosensor dip probe for quantitative estimation of interleukin-6 in serum samples (Journal of Biomedical Optics (2010) 15 (067005))Journal of Biomedical Optics.  16. 2011
2010 Bax expression is a candidate prognostic and predictive marker of colorectal cancer.Journal of Gastrointestinal Oncology.  1:76-89. 2010
2010 Development of combination tapered fiber-optic biosensor dip probe for quantitative estimation of interleukin-6 in serum samples.Journal of Biomedical Optics.  15:067005. 2010
2010 Standards for immunohistochemical imaging: a protein reference device for biomarker quantitation.Journal of Histochemistry and Cytochemistry.  58:1005-1014. 2010
2010 miRNAs as biomarkers for management of patients with colorectal cancer.Biomarkers in Medicine.  4:761-770. 2010
2010 Prognostic value of mucin 4 expression in colorectal adenocarcinomas.Cancer.  116:3577-3586. 2010
2010 Comparison of the predictive qualities of three prognostic models of colorectal cancer.Frontiers in bioscience (Elite edition).  2:849-856. 2010
2010 Smad signaling is required to maintain epigenetic silencing during breast cancer progression.Cancer Research.  70:968-978. 2010
2010 Quantitative Estimation of IL-6 in Serum/Plasma Samples Using a Rapid and Cost-Effective Fiber-Optic dip-probe.Proceedings of SPIE.  7559. 2010
2010 Development and progression of colorectal neoplasia.Cancer Biomarkers.  9:235-265. 2010
2010 The biology of incipient, pre-invasive or intraepithelial neoplasia.Cancer Biomarkers.  9:21-39. 2010
2010 Translational pathology of neoplasia.Cancer Biomarkers.  9:7-20. 2010
2009 Effect of comorbidity and body mass index on the survival of African-American and Caucasian patients with colon cancer.Cancer.  115:5798-5806. 2009
2009 Combined effects of formalin fixation and tissue processing on immunorecognition Fixation effects on immunostainingStain technology.  84:223-247. 2009
2009 Combined effects of formalin fixation and tissue processing on immunorecognition.Stain technology.  84:223-247. 2009
2009 Furthering the evidence-based management of dermatologic effects of EGFR inhibitor therapyCurrent Colorectal Cancer Reports.  5:179-181. 2009
2009 Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon cancer.Journal of Clinical Oncology.  27:4339-4345. 2009
2009 HIV Nef-M1 Effects on Colorectal Cancer Growth in Tumor-induced Spleens and Hepatic Metastasis.Molecular and Cellular Pharmacology.  1:85-91. 2009
2009 Detection of Merkel cell polyomavirus in formalin-fixed, paraffin-embedded tissue of Merkel cell carcinoma and its correlation with prognosis.Journal of Clinical Oncology.  27:6027. 2009
2009 Prognostic significance of VDR, DKK-1, and DKK-4 expression in colorectal cancer.Journal of Clinical Oncology.  27:e15047. 2009
2009 Immunohistochemical expression of rabphilin-3A-like (Noc2) in normal and tumor tissues of human endocrine pancreas.Stain technology.  84:39-45. 2009
2009 Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma.Clinical Cancer Research.  15:2406-2416. 2009
2008 Lynch syndrome in women less than 50 years of age with endometrial cancer.Obstetrics and Gynecology.  111:1161-1166. 2008
2008 p53 Nuclear accumulation and Bcl-2 expression in contiguous adenomatous components of colorectal adenocarcinomas predict aggressive tumor behavior.Journal of Histochemistry and Cytochemistry.  56:305-312. 2008
2008 Clinical significance of a novel single nucleotide polymorphism in the 5' untranslated region of the Rabphillin-3A-Like gene in colorectal adenocarcinoma.Frontiers in Bioscience.  13:1050-1061. 2008
2007 Predicting 5-year survival of colorectal carcinoma patients using data mining methods.AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium.  907. 2007
2007 Understanding racial differences in colorectal cancer aids in individualized medicine.Future Oncology.  3:235-241. 2007
2007 Comparison of predicted probabilities of proportional hazards regression and linear discriminant analysis methods using a colorectal cancer molecular biomarker database.Cancer Informatics.  3:115-122. 2007
2007 Methionine inhibits cellular growth dependent on the p53 status of cells.American Journal of Surgery.  193:274-283. 2007
2007 African-American and Caucasian disparities in colorectal cancer mortality and survival by data source: an epidemiologic review.Cancer Biomarkers.  3:301-313. 2007
2006 Biomarkers in Diagnosis of pancreatic carcinoma in fine-needle aspirates.American Journal of Clinical Pathology.  126:572-579. 2006
2006 Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations.Critical Reviews in Oncology/Hematology.  60:9-18. 2006
2006 Mucinous expression in benign and neoplastic glandular lesions of the uterine cervix.Archives of Pathology and Laboratory Medicine.  130:1510-1515. 2006
2006 Phenotypic expression of Bax is a predictive marker of 5-fluorouracil treatment in colorectal cancer.Journal of Clinical Oncology.  24:3605. 2006
2006 Biomarkers in diagnosis of pancreatic carcinoma in fine-needle aspirates: A translational research applicationAmerican Journal of Clinical Pathology.  126:572-579. 2006
2005 Recent advances in biomarkers for cancer diagnosis and treatment.Drug Discovery Today.  10:965-976. 2005
2005 High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas.Cancer.  103:2163-2170. 2005
2005 Recurrence and survival predictive value of phenotypic expression of Bcl-2 varies with tumor stage of colorectal adenocarcinoma.Cancer Biomarkers.  1:241-250. 2005
2005 the need for review and understanding of SELDI/MALDI mass spectroscopy data prior to analysis.Cancer Informatics.  1:86-97. 2005
2004 Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma.Cancer.  101:2899. 2004
2004 Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma.Cancer.  101:66-76. 2004
2004 Prognostic significance of p27(kip-1) expression in colorectal adenocarcinomas is associated with tumor stage.Clinical Cancer Research.  10:1743-1752. 2004
2003 MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.Cancer.  99:365-371. 2003
2003 The efficacy of 9-cis-retinoic acid (aliretinoin) as a chemopreventive agent for cervical dysplasia: results of a randomized double-blind clinical trial.Cancer Epidemiology, Biomarkers and Prevention.  12:114-119. 2003
2003 Nuclear accumulation of p53 is a potential marker for the development of squamous cell lung cancer in smokers.Chest.  123:181-186. 2003
2002 Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.Clinical Cancer Research.  8:734-744. 2002
2002 Quantitation of cytosine deaminase mRNA by real-time reverse transcription polymerase chain reaction: a sensitive method for assessing 5-fluorocytosine toxicity in vitro.Analytical Biochemistry.  301:189-199. 2002
2002 Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1).International Journal of Cancer.  97:403-409. 2002
2001 Altered subcellular localization of suppressin, a novel inhibitor of cell-cycle entry, is an independent prognostic factor in colorectal adenocarcinomas.Clinical Cancer Research.  7:3495-3503. 2001
2001 Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands.Laryngoscope.  111:1373-1378. 2001
2001 Nuclear accumulation of p53 is a potential marker for the development of squamous cell lung cancer in smokers.Federation proceedings.  15:A249-A249. 2001
2001 Molecular characterization of colorectal neoplasia in translational research.Archives of Pathology and Laboratory Medicine.  125:91-98. 2001
2000 Immunohistochemical evaluation of global DNA methylation: comparison with in vitro radiolabeled methyl incorporation assay.Stain technology.  75:251-258. 2000
2000 BC1-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomasInternational Journal of Cancer.  89:423-430. 2000
2000 Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas.Clinical Cancer Research.  6:4017-4025. 2000
2000 Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas.International Journal of Cancer.  89:423-430. 2000
2000 The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung.Human Pathology.  31:1068-1073. 2000
2000 The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung.Human Pathology.  31:482-487. 2000
2000 Elevated expression of fatty acid synthase (FASE) in squamous cell cancer of the lung.Federation proceedings.  14:A789-A789. 2000
1999 Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia.Journal of Urology, The.  162:1462-1466. 1999
1999 Androgenic regulation of growth factor and growth factor receptor expression in the CWR22 model of prostatic adenocarcinoma.International Journal of Cancer.  82:424-429. 1999
1999 Changes in cyclin dependent kinase inhibitors p21 and p27 during the castration induced regression of the CWR22 model of prostatic adenocarcinoma.Journal of Urology, The.  161:945-949. 1999
1999 Evaluation of biomarker modulation by fenretinide in prostate cancer patients.European Urology.  35:429-438. 1999
1998 Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumor.Cancer.  83:2456-2467. 1998
1997 Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma.International Journal of Cancer.  74:346-358. 1997
1997 Re: loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer.JNCI: Journal of the National Cancer Institute.  89:585-586. 1997
1997 The use of biomarker expression to characterize neoplastic processes.Stain technology.  72:96-104. 1997

Chapter

Year Title Altmetric
2012 Development and progression of colorectal neoplasia.  235-265. 2012

Principal Investigator On

  • 3/3 Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership  awarded by National Cancer Institute/NIH/DHHS 2016 - 2021
  • Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: (Admin Supplement) to Support Development of PDX at UAB CCC  awarded by National Cancer Institute/NIH/DHHS 2016 - 2021
  • Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Administrative Core  awarded by National Cancer Institute/NIH/DHHS 2016 - 2021
  • 1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership  awarded by National Cancer Institute/NIH/DHHS 2014 - 2019
  • 1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership - Administrative Core  awarded by National Cancer Institute/NIH/DHHS 2014 - 2019
  • 1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership - Pilot Project #1  awarded by National Cancer Institute/NIH/DHHS 2014 - 2019
  • Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership  awarded by National Cancer Institute/NIH/DHHS 2011 - 2016
  • Effects of NefM1 Peptide on Primary and Metastatic Colorectal Cancer Xenografts  awarded by Michigan State University 2013 - 2016
  • Predictive Molecular Markers of Colorectal Cancer  awarded by National Cancer Institute/NIH/DHHS 2009 - 2011
  • EDRN Project-Prognostic Markers in Lynch Syndrome Colorectal Cancers  awarded by CREIGHTON UNIVERSITY 2008 - 2011
  • Education And Training

  • Doctor of Philosophy in Zoology / Animal Biology, Osmania University
  • Full Name

  • Upender Manne
  • Blazerid

  • manne